These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3298936)

  • 1. Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus.
    Krarup T; Saurbrey N; Moody AJ; Kühl C; Madsbad S
    Metabolism; 1987 Jul; 36(7):677-82. PubMed ID: 3298936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitus.
    Jones IR; Owens DR; Vora J; Luzio SD; Hayes TM
    Diabetes Res Clin Pract; 1989 Nov; 7(4):263-9. PubMed ID: 2693029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Hayes TM
    Horm Metab Res; 1989 Jan; 21(1):23-6. PubMed ID: 2647605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS; Ryan AS; Minaker KL; Elahi D
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenously infused porcine GIP on serum insulin, plasma C-peptide, and pancreatic polypeptide in non-insulin-dependent diabetes in the fasting state.
    Amland PF; Jorde R; Aanderud S; Burhol PG; Giercksky KE
    Scand J Gastroenterol; 1985 Apr; 20(3):315-20. PubMed ID: 3890139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics.
    Krarup T; Madsbad S; Moody AJ
    Acta Med Scand; 1988; 223(5):437-41. PubMed ID: 3287838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of serial test meals on plasma immunoreactive GIP in non-insulin dependent diabetic patients and non-diabetic controls.
    Groop PH; Fyhrquist F; Groop LC
    Scand J Clin Lab Invest; 1985 Apr; 45(2):115-22. PubMed ID: 3890129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects.
    Meier JJ; Nauck MA; Siepmann N; Greulich M; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
    Metabolism; 2003 Dec; 52(12):1579-85. PubMed ID: 14669159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of insulin deprivation on fasting levels of 5000 dalton gastric inhibitory polypeptide in type 1 (insulin-dependent) diabetics.
    Krarup T; Madsbad S; Regeur L; Alberti KG; Faber OK; Kurtz A
    Diabete Metab; 1985 Dec; 11(6):364-7. PubMed ID: 3910488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.
    Krarup T; Madsbad S; Regeur L; Faber OK; Tronier B
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
    Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
    J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric inhibitory polypeptide (GIP): a therapeutic possibility?
    Moody AJ; Jones IR; Krarup T; Owens DR; Saurbrey N
    Acta Paediatr Scand Suppl; 1985; 320():66-71. PubMed ID: 3914816
    [No Abstract]   [Full Text] [Related]  

  • 18. The glucose dependent insulinotropic polypeptide response to oral glucose and mixed meals is increased in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Jones IR; Owens DR; Luzio S; Williams S; Hayes TM
    Diabetologia; 1989 Sep; 32(9):668-77. PubMed ID: 2676668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.
    Meneilly GS; Bryer-Ash M; Elahi D
    Diabetes Care; 1993 Jan; 16(1):110-4. PubMed ID: 8422763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
    Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
    Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.